首页> 外文期刊>The Clinical biochemist. Reviews >Application of the Stockholm Hierarchy to Defining the Quality of Reference Intervals and Clinical Decision Limits
【24h】

Application of the Stockholm Hierarchy to Defining the Quality of Reference Intervals and Clinical Decision Limits

机译:斯德哥尔摩层次结构在定义参考区间和临床决策限制的质量中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

The Stockholm Hierarchy is a professional consensus created to define the preferred approaches to defining analytical quality. The quality of a laboratory measurement can also be classified by the quality of the limits that the value is compared with, namely reference interval limits and clinical decision limits. At the highest level in the hierarchy would be placed clinical decision limits based on clinical outcome studies. The second level would include both formal reference interval studies (studies of intra and inter-individual variations) and clinical decision limits based on clinician survey. While these approaches are commonly used, they require a lot of resources to define accurately. Placing laboratory experts on the third level would suggest that although they can also define reference intervals by consensus, theirs aren't as well regarded as clinician defined limits which drive clinical behaviour. Ideally both analytical and clinical considerations should be made, with clinicians and laboratorians both having important information to consider. The fourth level of reference intervals would be for those defined by survey or by regulatory authorities because of the focus on what is commonly achieved rather than what is necessarily correct. Finally, laboratorians know that adopting reference limits from kit inserts or textbook publications is problematic because both methodological issues and reference populations are often not the same as their own. This approach would rank fifth and last. When considering which so called 'common' or 'harmonised reference intervals' to adopt, both these characteristics and the quality of individual studies need to be assessed. Finally, we should also be aware that reference intervals describe health and physiology while clinical decision limits focus on disease and pathology, and unless we understand and consider the two corresponding issues of test specificity and test sensitivity, we cannot assure the quality of the limits that we report.
机译:斯德哥尔摩层次结构是一种专业共识,旨在定义定义分析质量的首选方法。实验室测量的质量也可以通过将值与之比较的限值的质量进行分类,即参考间隔限值和临床决策限值。将基于临床结果研究将临床决策限制置于层次结构的最高级别。第二级将包括正式的参考区间研究(个体内部和个体间差异的研究)和基于临床医生调查的临床决策范围。虽然通常使用这些方法,但它们需要大量资源才能准确定义。将实验室专家放在第三级会建议,尽管他们也可以通过共识来定义参考间隔,但他们并没有被视为临床医生定义的限制临床行为的限制。理想情况下,应同时进行分析和临床考虑,临床医生和实验室医生均应考虑重要信息。参考间隔的第四级适用于由调查或监管机构定义的参考间隔,因为关注的是通常实现的目标,而不是必须正确的目标。最后,实验室人员知道采用试剂盒插入物或教科书出版物中的参考限量存在问题,因为方法学问题和参考人群常常与他们自己不同。这种方法将排在第五和最后。在考虑采用哪个“共同的”或“统一的参考区间”时,需要评估这些特征和个别研究的质量。最后,我们还应该意识到,参考间隔描述了健康和生理,而临床决策限制集中在疾病和病理上,除非我们理解并考虑了两个相对应的测试特异性和测试敏感性问题,否则我们无法保证这些限制的质量我们报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号